Corindus Vascular Robotics (CVRS) Misses Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Corindus Vascular Robotics Reports Third Quarter 2016 Results
November 8, 2016 4:05 PM ESTWALTHAM, Mass.--(BUSINESS WIRE)-- Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics, today reported financial results for the three and nine month periods ended September 30, 2016.
Recent Highlights and Accomplishments
Realized revenue of $688,000 in the third quarter of 2016, primarily from CorPath® System revenue as well as cassette, accessory and service revenue Installed one new CorPath... More


